| |
| |
|
| Insider
Information: |
Rosenbaum David P. |
| Relationship: |
Chief Development Offi... |
| City: |
Fremont |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
376,479 |
|
|
Indirect Shares
|
236,094 |
|
|
| Direct
Value |
$2,300,287 |
|
|
|
Indirect Value
|
$1,442,534 |
|
|
| Total
Shares |
612,573 |
|
|
| Total
Value |
$3,742,821 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
36
|
|
Stock
price went up :
|
1
|
23
|
| Stock
price went down : |
0
|
13
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.8
|
| Percentage
Gain/Loss : |
 276.6%
|
2,864.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardelyx Inc |
ARDX |
Chief Development Offi... |
2024-06-03 |
376,479 |
2024-06-03 |
236,094 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
79 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-02-22 |
4 |
S |
$6.88 |
$1,328 |
I/I |
(193) |
29,969 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2019-01-02 |
4 |
S |
$1.70 |
$1,363 |
I/I |
(801) |
18,029 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2022-08-22 |
4 |
S |
$0.98 |
$1,434 |
D/D |
(1,458) |
302,458 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2022-08-31 |
4 |
B |
$0.62 |
$1,856 |
I/I |
3,000 |
92,369 |
1.91 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2022-09-01 |
4 |
S |
$0.92 |
$2,760 |
I/I |
(3,000) |
89,369 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2022-11-22 |
4 |
S |
$1.94 |
$2,853 |
D/D |
(1,464) |
300,994 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-08-21 |
4 |
S |
$3.55 |
$3,328 |
I/I |
(937) |
111,225 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-02-21 |
4 |
S |
$3.00 |
$3,343 |
I/I |
(1,114) |
113,096 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-05-23 |
4 |
S |
$3.65 |
$3,412 |
I/I |
(934) |
112,162 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-11-20 |
4 |
S |
$4.36 |
$4,066 |
I/I |
(932) |
113,293 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-02-22 |
4 |
S |
$6.88 |
$4,212 |
D/D |
(612) |
165,047 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2021-05-20 |
4 |
S |
$7.09 |
$4,338 |
D/D |
(612) |
159,435 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-10-10 |
4 |
AS |
$4.00 |
$6,576 |
D/D |
(1,644) |
365,378 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2019-06-04 |
4 |
S |
$2.54 |
$7,258 |
D/D |
(2,856) |
160,171 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2019-01-02 |
4 |
S |
$1.70 |
$9,503 |
D/D |
(5,585) |
160,027 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-08-21 |
4 |
S |
$3.55 |
$10,108 |
D/D |
(2,846) |
369,919 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-02-21 |
4 |
S |
$3.00 |
$10,185 |
D/D |
(3,394) |
375,600 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-05-23 |
4 |
S |
$3.65 |
$10,357 |
D/D |
(2,835) |
372,765 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2022-06-06 |
4 |
S |
$0.64 |
$11,474 |
I/I |
(17,636) |
89,866 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2016-03-03 |
4 |
AS |
$10.74 |
$12,110 |
D/D |
(1,128) |
22,144 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• – – |
2023-11-20 |
4 |
S |
$4.36 |
$12,367 |
D/D |
(2,835) |
362,543 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2016-12-16 |
4 |
S |
$14.48 |
$13,035 |
I/I |
(900) |
636 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
Chief Development Officer |
• • – |
2023-09-08 |
4 |
AS |
$4.55 |
$13,181 |
D/D |
(2,897) |
367,022 |
0 |
% |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-22 |
4 |
AS |
$22.00 |
$13,200 |
D/D |
(600) |
73,652 |
0 |
- |
|
| ARDX |
Ardelyx Inc |
SVP, Drug Development |
• – – |
2015-09-22 |
4/A |
AS |
$22.00 |
$13,200 |
D/D |
(600) |
21,940 |
0 |
- |
|
79 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
